Associated Papers
Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.
Chiricozzi E et al.
Molecular Neurobiology, 2014
Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis.
Maegawa GH et al.
The Journal of Biological Chemistry, 2007
Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
Akerman BR et al.
American Journal of Human Genetics, 1997
Select a paper to view details